Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Revenue
€ 7.8 million
▼ 7% vs 2024
Profit
Caution€ -42,260
▲ 97% vs 2024
Debts
Low€ 14.2 million
▼ 26% vs 2024
NEWPHARMA GROUP from Liège, company number BE0684465652, closed financial year 2025 with a result of € -42,260 after tax. For that financial year NEWPHARMA GROUP recorded revenue of € 7.8 million and equity of € 86.7 million. Compared with financial year 2024, the result moved from € -1.2 million to € -42,260. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2025.
What happened at NEWPHARMA GROUP?
What happened at NEWPHARMA GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- JEF COLRUYT stepped down as director. NBB
- KRIS CASTELEIN stepped down as director. NBB
- JO WILLEMYNS stepped down as director. NBB
- STEFAAN VANDAMME stepped down as director. NBB
- STEFAN GOETHAERT stepped down as director. NBB
- GJ Lifescience management SRL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 42,260. Source: NBB ↗
- JEF COLRUYT became a director. NBB
In short
From € 726,820 loss in 2021 to € 42,260 loss in 2025.
Paid € 68,202 in corporate taxes since 2021.
Pays suppliers within 176 days on average.
A new publication or filing at NEWPHARMA GROUP? We notify you, reason included.
Follow NEWPHARMA GROUPNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Sukhino SA (100%). It owns 100% of Apotheek Beaujean Centrum, 100% of Z+ PHARMA, 100% of MEGAPARA SAS, 100% of APOTHEEK NOORDERLAAN, 100% of SMARTVALUE and 100% of SMARTVALUE DISTRIBUTION SRL itself.
Directors
According to the 2025 annual accounts
JEF COLRUYT
Director
Also active at: Colruyt Group, Roelandt, RETAIL PARTNERS COLRUYT GROUP +16 more
since 2023 · until 2028
since 2023 · until 2028
JO WILLEMYNS
Director
Also active at: Roelandt, RETAIL PARTNERS COLRUYT GROUP, SOCIETE AGRICOLE de MEESTER +13 more
since 2023 · until 2028
since 2023 · until 2028
Managing director · represented by GILLES JOURQUIN
Also active at: Smartvalue, NEWPHARMA
since 2021 · until 2027
STEFAN GOETHAERT
Director
Also active at: Colruyt Group, Roelandt, RETAIL PARTNERS COLRUYT GROUP +16 more
since 2023 · until 2028
Shareholders
100%
Participations
100%
MEGAPARA SAS
100%
100%
100%
0.4%
Establishments
Establishment units
Physical locations of this company
Rue du Charbonnage 9
4020 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0684.465.652
- VAT number
- BE 0684.465.652
- Registered office
- Rue du Charbonnage 9, 4020 Liège
- Names & denominations
- NEWPHARMA GROUP
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 November 2017
- Peppol
- Active · Active since 3 Sept 2025
- Activities · NACE
Activiteiten van hoofdkantoren
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering